NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, Canada, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTCQB: ORRCF) confirms that the non-brokered private placement financing, announced on September 25, 2025, is proceeding as planned and will be completed within the necessary regulatory timeframe. The Offering is for up to 18,000,000 Units at a price of US$0.20 per Unit (for aggregate gross proceeds of up to US$3.6 million, with an an ...

Earnings Release: Tuesday, November 4, 2025, Before Market OpensConference Call and Webcast: Tuesday, November 4, at 8:30 a.m. ET MONACO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Costamare Inc. (NYSE:CMRE) (the “Company”), announced today that it will release its results for the third quarter ended September 30, 2025 before the market opens in New York on November 4, 2025. Conference Call Details: On Tuesday, November 4, 2025 at 8:30 a.m. ET, Costamare’s management team will hold a conference call to discuss the ...

Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug, in combination with KEYTRUDA with up to 30 patients per arm Company anticipates trial completion in early 2027, and potential updates in 2026 Additional updates from the ongoing Phase 1b/2 trial with muzastotug, previously reported at ASCO 2025, are anticipated in the coming months SAN DIEGO and SUZHOU, China, ...

MONTREAL, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Falco Resources Ltd. (TSX.V: FPC) (“Falco” or the “Corporation”) is pleased to announce that the Corporation has entered into binding agreements (i) with OR Royalties Inc. (“OR Royalties”) in order to extend the maturity date of the Corporation’s existing convertible secured senior loan (the “OR Royalties Loan”) from December 31, 2025, to December 31, 2026; and (ii) with Glencore Canada Corporation (“Glencore”) in order to extend the maturity date of the Corporati ...

PRINCETON, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November. 2025 UBS Global Healthcare Conference in Palm Beach Gardens, FL on Monday, November 10, 2025, at 2:45 p.m. ETJefferies Global Healthcare Conference 2025 in London, U.K. on Tuesday, November 18, 2025, at 4:30 p.m. GMT A live audio webcast of each presentation can also be accessed via the investors se ...

US Treasury Loan Update PHOENIX, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today announced that it has entered into an Amendment (the “Amendment”) to its Loan and Guarantee Agreement, dated as of October 30, 2020 (as theretofore amended, the “Loan Agreement”), among the Company, Mesa Airlines, the Guarantors party thereto from time to time, Jefferies Capital Services, LLC (as successor in interest to the United States Department of the Treasury) (the “Le ...

Randomized controlled trial results published in the International Journal of Tissue Repair demonstrate BioRetain® allografts significantly improve probability of achieving lasting wound closure versus standard of carePOMPANO BEACH, Fla., Oct. 31, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced top-line ...

QUEBEC CITY, Oct. 31, 2025 (GLOBE NEWSWIRE) -- West African gold producer and developer Robex Resources Inc. (“Robex” or the “Company”) (TSX-V: RBX | ASX: RXR | OTC: RSRBF | Börse Frankfurt: RB4) is pleased to report on its activities for the September 2025 Quarter. Robex owns the Nampala Gold Mine in Mali and continues to make strong progress on the construction of the Kiniero Gold Project in Guinea, which remains on schedule for first gold pour in Q4 CY25. Highlights: Robex and Predictive Discovery (ASX: ...

SEATTLE, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming conferences: Truist Securities BioPharma Symposium – 1x1 onlyDate: Thursday, November 6, 2025Location: New York, NY ...

WALTHAM, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Chief Executive Officer of Upstream Bio, will be participating in the following upcoming investor conferences in November: 2025 Truist Securities BioPharma Symposium, New York, NYThursday, November 6, 2025, Panel - 8:10 a.m. ETStifel 2025 Healthcare Confere ...